MTOR and acute lymphoblastic leukemia: In acute lymphoblastic leukemia Philadelphia chromosome-positive (Ph + ALL), it was demonstrated that curcumin potentiated the efficiency of imatinib by inhibiting the activation of the AKT/mTOR signaling and by down-regulating the expression of the BCR/ABL gene [40].